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Wastewater analysis has been demonstrated to be a complementary approach for assessing the overall 
patterns of drug use by a population while the full potential of wastewater-based epidemiology has 
yet to be explored. F2-isoprostanes are a prototype wastewater biomarker to study the cumulative 
oxidative stress at a community level. In this work, 8-iso-prostaglandin F2α (8-iso-PGF2α) was analysed 
in raw 24 h-composite wastewater samples collected from 4 Norwegian and 7 other European cities 
in 2014 and 2015. Using the same samples, biomarkers of alcohol (ethyl sulfate) and tobacco (trans-
3′-hydroxycotinine) use were also analysed to investigate any possible correlation between 8-iso-
PGF2α and the consumption of the two drugs. The estimated per capita daily loads of 8-iso-PGF2α in 
the 11 cities ranged between 2.5 and 9.9 mg/day/1000 inhabitants with a population-weighted mean 
of 4.8 mg/day/1000 inhabitants. There were no temporal trends observed in the levels of 8-iso-PGF2α, 
however, spatial differences were found at the inter-city level correlating to the degree of urbanisation. 
The 8-iso-PGF2α mass load was found to be strongly associated with that of trans-3′-hydroxycotinine 
while it showed no correlation with ethyl sulfate. The present study shows the potential for 8-iso-PGF2α 
as a wastewater biomarker for the assessment of community public health.
Wastewater contains numerous endogenous and exogenous compounds excreted by humans as the result of 
metabolism. Some of these compounds can provide both direct and indirect information on specific diseases as 
well as the general health status of an individual1,2. The analysis of these biomarkers in urine has subsequently 
been established as diagnostic and prognostic tools for clinical research. Since in many developed countries the 
general population is connected to a sewer network, combining the urine from a defined population, this in 
theory facilitates the potential for analysing these biomarkers in wastewater as a means of providing information 
on the general health status of the said population3. An emerging field, wastewater-based epidemiology (WBE), 
relies on this concept and utilises wastewater as pooled urine as a source of information on public health. The 
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usefulness of WBE has been demonstrated in the field of drug epidemiology by assessing the spatial and temporal 
trends of drug use in different communities4–8. Furthermore, there have been attempts to extend this approach 
for endogenously produced compounds that are directly associated with health and disease (e.g. oxidative stress9 
and cancer10,11).
Oxidative stress is generally defined as the disruption in redox signalling and control, often caused by the 
imbalance in the level of prooxidants relative to antioxidants12. Oxidative stress is suspected to play a key role in 
the pathogenesis of various diseases including the top major causes of death in the world (ischemic heart disease13, 
stroke14, lower respiratory infections15,16 and chronic obstructive lung disease17). Consequently, a number of 
studies have focused on the measurement of oxidative stress, many of which are through specific biomarkers 
that indicate the oxidative damage18. Biomolecules such as lipid, protein and DNA are the targets of reactive oxy-
gen/nitrogen species (generated by prooxidants) that are subsequently transformed into the unique compounds 
reflecting oxidative stress in the corresponding molecules (e.g. isoprostanes19, 3-nitrotyrosine20 and 8-hydroxy- 
2′ -deoxyguanosine21).
Isoprostanes have been accepted as a reliable biomarker of oxidative stress and their use in clinical research 
is well established22. As isoprostanes originate from lipid membranes in every tissue of the human body, their 
levels provide a systematic and integrated measure of oxidative stress. Among the three major classes (F2-, 
D2- and E2-) of isoprostanes, F2-isoprostanes have been recognised as the most suitable biomarker since D2- 
and E2-isoprostanes are less stable23. F2-isoprostanes have been measured in a wide range of biological sam-
ples such as urine, plasma and exhaled breath condensate24. Furthermore, the potential of F2-isoprostanes as 
health biomarkers in WBE has been thoroughly reviewed based on biomarker selection criteria25. For a uri-
nary biomarker to be suitable for use in WBE it needs to be stable in wastewater, excreted via urine at suffi-
ciently high concentrations for quantification, specific to humans, and sensitive to the changes in the endpoint 
under investigation25. Subsequently, any compounds that meet these criteria can be used. Following an exten-
sive literature review, F2-isoprostanes have been suggested as a prototype wastewater biomarker for public 
health assessment25 and thereafter, an analytical method for the most extensively studied F2-isoprostane isomer, 
8-iso-prostaglandin F2α (8-iso-PGF2α), in wastewater has been developed using immunoaffinity clean-up with 
liquid chromatography-high resolution mass spectrometry (IAC-LC-HRMS)9. In the latter study, 8-iso-PGF2α 
was demonstrated to be stable in wastewater at least for 24 hours.
Association of oxidative stress with specific disease or health has been investigated in a number of studies 
that have reported the levels of F2-isoprostanes in urine26,27. The factors that have been correlated with urinary 
F2-isoprostane levels include various diseases such as diabetes28,29, cardiovascular diseases30 and cancer31 as well 
as lifestyles variables (e.g. smoking and alcohol consumption)25. It has been shown that smoking and alcohol 
consumption are the factors that most strongly correlate with increases of several folds in relative F2-isoprostane 
levels compared to controls25.
In WBE studies, tobacco use can be estimated by the analysis of two urinary metabolites of nicotine; coti-
nine and trans-3′ -hydroxycotinine32–36. While enzymatic deconjugation is necessary to quantify total cotinine in 
wastewater, there has been no significant difference observed between measurements made with and without the 
enzyme treatment for trans-3′ -hydroxycotinine32. When total concentrations are measured, both biomarkers pro-
vide very similar data for tobacco consumption32. The ethanol conjugates, ethyl glucuronide and ethyl sulfate are 
minor metabolites excreted into urine following alcohol intake37. Their suitability as wastewater biomarkers for 
estimation of alcohol consumption was first investigated by Reid and colleagues in 201138. The study has demon-
strated the high stability of ethyl sulfate in wastewater, in contrast to the rapid degradation of ethyl glucuronide38.
The aim of this work is to analyse 8-iso-PGF2α, in wastewater samples collected from 11 European cities and 
to investigate the possible correlation of 8-iso-PGF2α levels to tobacco and alcohol uses. The temporal and spatial 
patterns of 8-iso-PGF2α are evaluated to assess the suitability of this compound as a biomarker of population 
health in wastewater. The consumption of tobacco and alcohol has been measured in the same samples that were 
mentioned above using their specific biomarkers, trans-3′ -hydroxycotinine and ethyl sulfate, respectively.
Results
8-iso-PGF2α analysis. 8-iso-PGF2α was quantified in every wastewater sample with concentrations rang-
ing from 8.7 to 18.0 ng/L (see Supplementary Table S1). The measured weekday and weekend loads in 11 cities 
(population-weighted mean) were 4.6 and 4.7 mg/day/1000 inhabitants, respectively. There was no significant 
difference (Wilcoxon, α = 0.05) between the weekday and weekend loads of 8-iso-PGF2α. Median per capita loads 
of 8-iso-PGF2α in each city estimated by Monte Carlo simulation ranged from 2.5 to 9.9 mg/day/1000 inhabitants 
as shown in Fig. 1. Daily loads of 8-iso-PGF2α in wastewater from the Norwegian cities (Oslo, Hamar, Stavanger 
and Tromsø) and Zurich were estimated to be the highest compared to all other cities. The estimated mean daily 
load from all the 11 cities (population-weighted) was 4.8 mg/day/1000 inhabitants (95% credible interval 4.3–5.4).
We also performed intra-city comparisons for Oslo using the previously reported levels of 8-iso-PGF2α in the 
city9 in order to assess whether the load of this biomarker has changed over time. It was shown that there was no 
statistically significant difference between the loads measured in November 2014 (this study) and those in March 
20159 (Wilcoxon, α = 0.05). In addition, no weekly pattern (weekday vs. weekend) in the load could be observed 
in these intra-city comparisons (Wilcoxon, α = 0.05).
The total uncertainties, defined as the ratio between standard deviation and mean of a simulated value7,39, 
ranged between 12 and 17%. The overall uncertainty obtained was lower for the cities with longer periods of 
sampling (i.e. Norwegian cities and Milan) since there was little day-to-day variation in the loads of 8-iso-PGF2α 
in each city, as well as the sampling error would be reduced by the square root of the number of samples7. In 
addition, the errors associated with population estimation and flow measurement were found to be the most 
dominant factors influencing the total uncertainty.
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Association with tobacco and alcohol consumption. Multiple linear regression (MLR) analysis was 
performed to investigate the contribution of alcohol and tobacco consumption to oxidative stress level in the 
population. Table 1 presents the results of MLR analysis with log-transformed loads of 8-iso-PGF2α as outcome 
and loads of trans-3′ -hydroxycotinine together with log-transformed loads of ethyl sulfate as predictors. Even 
though the correlation was found to be stronger during weekdays, the MLR analysis consistently showed trans-
3′ -hydroxycotinine was statistically significant in all regression models, whereas log ethyl sulfate had no sig-
nificant association with log 8-iso-PGF2α (see Supplementary Fig. S1). As shown in Fig. 2, log 8-iso-PGF2α is 
positively correlated with trans-3′ -hydroxycotinine, with an increase of 19% for every increasing unit of trans-3′ - 
hydroxycotinine load in wastewater.
The significant association observed between oxidative stress and tobacco use biomarkers in wastewater is in 
accordance with previous reports that have shown an increase in urinary 8-iso-PGF2α concentrations induced by 
Figure 1. Estimated population-normalised daily loads of 8-iso-PGF2α in the 11 cities. Estimates are 
presented as median with 95% credible interval based on the Monte Carlo simulations.
Predictors
Total (n = 38) Weekday (n = 19) Weekend (n = 19)
Regression coefficient 
(95% confidence interval)
P 
value
Regression coefficient 
(95% confidence interval)
P 
value
Regression coefficient 
(95% confidence interval)
P 
value
Constant 0.32 (0.15, 0.48) < 10−3 0.29 (0.05, 0.54) 0.023 0.35 (0.08, 0.62) 0.015
Log (ethyl sulfate) − 0.13 (− 0.35, 0.10) 0.268 − 0.20 (− 0.59, 0.20) 0.318 − 0.08 (− 0.44, 0.29) 0.654
Trans-3′ -hydroxycotinine 0.19 (0.12, 0.27) < 10−4 0.22 (0.11, 0.34) 0.001 0.17 (0.04, 0.30) 0.016
R2 = 0.42, adjusted R2 = 0.39, 
p < 10−4
R2 = 0.49, adjusted R2 = 0.44, 
p = 0.003
R2 = 0.36, adjusted R2 = 0.27, 
p = 0.037
Table 1.  Multiple linear regression results using log 8-iso-PGF2α as dependent variable and log ethyl 
sulfate together with trans-3′-hydroxycotinine as independent variables.
Figure 2. Partial regression plot between log 8-iso-PGF2α and trans-3′-hydroxycotinine in the multiple 
linear regression model based on both weekday and weekend. 8-iso-PGF2α data for Oslo was taken from our 
previous report9.
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smoking. The average per capita loads of the two biomarkers calculated for each city were moderately correlated 
(ρ = 0.7, p = 0.07), which is also visible in Fig. 2 where the data points are generally clustered based on sampling 
location. Furthermore, an improved relationship was obtained when the observations from Milan were removed 
(ρ = 0.8, p = 0.02). The same trend (increase in correlation) was also observed in the MLR analysis for the data set 
excluding Milan (see Supplementary Fig. S2).
Discussion
The present work is the first multi-city study reporting the measurement and comparison of the endogenous bio-
marker 8-iso-PGF2α in wastewater. The measured values (8.7–18.0 ng/L) are in the range that is comparable with 
the concentrations reported in Oslo, March 2015 (18.9–23.3 ng/L)9. Even though a number of studies have meas-
ured the urinary level of 8-iso-PGF2α in humans, most of them were either normalised against creatinine or only 
reported as concentrations that cannot be reliably compared with the values obtained in this study25. However, 
our estimates are in the similar range of the urinary 8-iso-PGF2α levels reported as total daily mass (which can 
translate into 0.5–5 mg/day/1000 inhabitants)25 (Fig. 1).
The number of endogenous biomarkers excreted by humans that were successfully quantified in wastewater 
is very limited9,40,41. Furthermore, only one of those focused on an endogenous biomarker as an indicator for 
the overall health of population (8-iso-PGF2α)9 while another two studies investigated the use of endogenous 
biomarkers for estimating population size (5-hydroxyindoleacetic acid40 and DNA41). The development and val-
idation of endogenous biomarkers for the assessment of public health through WBE is indeed complicated since 
there are a limited number of validated endogenous urinary biomarkers for routine clinical use. In comparison 
to exogenous biomarkers, produced following the exposure or consumption of specific substances, the selection 
of endogenous biomarkers is almost exclusively based on previous clinical studies. Therefore, F2-isoprostanes, 
selected following a thorough literature review25, are nonetheless the best candidate endogenous biomarker thus 
far, although it is certainly possible that there can be other suitable wastewater biomarkers to further support the 
feasibility of using WBE for monitoring community health. In addition, the extensive volume of relevant litera-
ture is another advantage of conducting further research on F2-isoprostanes for demonstrating the potential and 
amount of information that wastewater would possess in regards to community health.
As has been demonstrated in previous multi-city WBE studies, each community has different patterns of 
wastewater biomarkers related to lifestyle (e.g. drug use6,7). Our results are an extension of this concept and 
show that the level of a biomarker of health status, 8-iso-PGF2α, was distinguishable depending on the city with 
differences observed at both intra-and inter-national level. Furthermore, the level of 8-iso-PGF2α was shown to 
be significantly correlated with trans-3′ -hydroxycotinine, a biomarker of tobacco consumption, suggesting that 
the effect of smoking on oxidative stress can be observed at the population level through wastewater analysis. It 
should be also noted that a higher correlation between 8-iso-PGF2α and trans-3′ -hydroxycotinine was observed 
in MLR by excluding the results for Milan. Considering that 8-iso-PGF2α in the samples from Milan was analysed 
in the country of origin, the importance of method comparability is highlighted in this instance42. These results 
nonetheless support the potential for 8-iso-PGF2α to be used as a wastewater biomarker that can reflect the health 
status of the specific population connected by a sewer network.
The relationship between tobacco consumption and various negative health outcomes has been demonstrated 
in a number of studies. In particular, oxidative stress has been shown to be a central factor in the pathogene-
sis of the diseases related to tobacco consumption and lipid peroxidation is part of the mechanisms43,44. The 
lipid peroxidation biomarker, F2-isoprostanes, have been found to be present at levels several fold higher in the 
subjects exposed to both active and passive tobacco smoke25. The level of urinary 8-iso-PGF2α is known to be 
sensitive to quitting and then restarting tobacco consumption25. At the population level, however, this change 
cannot be observed in a short time frame as the prevalence and the amount of tobacco consumption are rather 
consistent33,34. Accordingly, loads of trans-3′ -hydroxycotinine as well as 8-iso-PGF2α in each city from the present 
study were stable during the sampling period. On the contrary, alcohol consumption has a clear weekly pattern 
with an increase occurring during the weekend45. Even though the level of F2-isoprostanes in urine has been 
demonstrated to show a strong positive correlation with alcohol consumption including acute use46, the oxida-
tive stress induced by alcohol consumption has not been visible in this study. This may be due to the fact that 
ethyl sulfate is excreted exclusively by the population that has consumed alcohol47 (mostly adults) while trans-3′ - 
hydroxycotinine also reflects passive exposure to tobacco smoking48, thereby excreted by a larger population.
It was notable that a spatial difference for the 8-iso-PGF2α per capita loads was observed within Norway in 
the same order as the size of the city’s population. Statistical tests revealed that Oslo has significantly higher 
8-iso-PGF2α level compared to the Norwegian cities of Tromsø and Hamar (Wilcoxon, α = 0.05) suggesting 
that the more urbanised region is likely to be exposed to higher oxidative stress. Unfortunately, the alcohol and 
tobacco biomarkers were not analysed in the other Norwegian samples than Oslo, and therefore it was not possi-
ble to see whether the 8-iso-PGF2α loads adjusted for tobacco use would show the same trend. However, it is rea-
sonable to hypothesise that the spatial variation is due to the degree of urbanisation as tobacco use is considered 
to be homogenous within Norway. Such an “urban factor” has been also reported in the previous studies carried 
out in Italy49,50.
Since F2-isoprostanes are a measure of collective oxidative stress as mentioned above, various other factors, 
not only tobacco consumption or urbanisation, can affect the urinary F2-isoprostanes. These variables include 
normal biological processes and therefore, our results should not be interpreted in a dichotomous way depending 
on the level of 8-iso-PGF2α in wastewater sample (i.e. healthy vs. diseased community). Indeed, a longer period 
of monitoring is required to prove the added value of F2-isoprostanes as a wastewater biomarker of community 
health. The temporal and spatial trends measured over a substantially long time would then provide the reference 
intervals of 8-iso-PGF2α in wastewater.
www.nature.com/scientificreports/
5Scientific RepoRts | 6:39055 | DOI: 10.1038/srep39055
In conclusion, a reliable oxidative stress biomarker, 8-iso-PGF2α, has been quantified in the wastewater sam-
ples from 11 European cities. The estimated per capita load within city was relatively stable throughout the sam-
pling period. Inter-city difference was observed, however the range of simulated values was comparable to the 
results from urinary analysis. A significant correlation of the oxidative stress biomarker with tobacco consump-
tion was found by MLR analysis, as well as in Norway the level of 8-iso-PGF2α increased depending on the degree 
of urbanisation. Our results support the hypothesis that wastewater is a pooled urine sample that reflects col-
lective information for the health of the entire population. However, further studies are required to equivocally 
confirm the suitability of 8-iso-PGF2α as a wastewater biomarker for community health assessment.
Methods
Wastewater samples. Wastewater was collected from 4 Norwegian and 7 other European cities in 2014 
and 2015. Sample collection in Norway was conducted eight times per city (4 weekday + 4 weekend samples for 
each city) within approximately one month. Since weekend samples in the Norwegian cities were not available on 
daily basis, weekend sampling was performed for 72 h, from Friday to Sunday. Samples from the other European 
cities were collected four times within one week (2 weekday + 2 weekend samples) except for Milan where 7 con-
secutive daily samples were available. Samples were shipped frozen to Oslo and Milan for analysis. Details on the 
sampling can be found in the Supplementary Information (see Supplementary Table S1).
Chemical analysis. The wastewater samples were analysed for 8-iso-PGF2α, trans-3′ -hydroxycotinine and 
ethyl sulfate using previously validated methods9,34,38. All the methods include the use of deuterated internal 
standards and liquid chromatography coupled with mass spectrometry for ensuring appropriate quantification of 
target compounds in the complex matrix, wastewater. With the exception of the samples from Milan, 8-iso-PGF2α 
analysis was conducted in Oslo by treating 100 mL of the sample with β -glucuronidase prior to IAC-LC-HRMS 
analysis9. Milan samples were prepared following the same protocol (β -glucuronidase treatment and IAC) but 
analysed by liquid chromatography coupled with tandem mass spectrometry (LC-MS/MS) in the country of 
origin. The details of LC-MS/MS analysis for 8-iso-PGF2α in Milan can be found in Supplementary Table S2. The 
analysis of trans-3′ -hydroxycotinine was carried out in Milan by extracting 3 mL of wastewater sample with HLB 
cartridge (3 mL, 60 mg) from Waters (Milford, MA, USA) before injecting into LC-MS/MS system34. Ethyl sulfate 
in wastewater samples was analysed in Oslo incorporating centrifugation (20,000 × g, 10 min) prior to ion-pair 
LC-MS/MS38. A summary of the validation data from the analytical methods employed in this study is reported 
in Supplementary Table S3.
Back-calculations and data analysis. Daily mass loads of each biomarker were back-calculated by mul-
tiplying the concentrations in samples with the corresponding daily volumes of wastewater. Since the week-
end samples from Norway were collected from Friday to Sunday as mentioned above, the weekend loads for 
Norwegian cities were divided by three to convert them into the average daily loads for weekend days. In order 
to compare the loads from cities with different population sizes, the daily mass loads were normalised by the 
wastewater catchment area’s population. Following previous studies7,45, Monte Carlo simulations (@RISK version 
7.0.1, Palisade Corporation, Ithaca, NY, USA) were used to estimate daily mass loads of 8-iso-PGF2α. The overall 
uncertainty associated with the estimated per capita mass loads of 8-iso-PGF2α was also assessed for each city by 
taking into account the errors of sampling, wastewater flow measurement, biomarker concentration, and popula-
tion estimation. The systematic errors considered in the Monte Carlo simulation were as follows: 5% for sampling, 
20% for flow measurement, precision of the analytical method (relative standard deviation) for the concentration 
and 20% for population size (see Supplementary Table S4 for details).
In addition, statistical analyses were carried out with SPSS Statistics 22.0 (SPSS Inc, Chicago, IL, USA) to 
compare average per capita loads of weekday with those of weekend and to assess the association of 8-iso-PGF2α 
with drug biomarker level in wastewater. Log-transformation was executed prior to further analysis when the 
data was skewed.
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